BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC for BOEHRINGER INGELHEIM USA CORPORATION
What was lobbied
6 issue areas, each in the filer's own words, with who lobbied on it and where.
Animals ANI
Illegal Compounding of Animal Drugs
| Lobbyist | Covered position, as disclosed |
|---|---|
| AMY CHEVALIER EFANTIS | — |
| ALANNA PORTER TEMME | — |
Health Issues HCR
Cost Sharing (Preserving Access to Medicines); CMS Proposed Rule (Protected Classes, etc.); "Hard to Obtain"; Risk Evaluation and Mitigation Strategies (REMS); Healthcare Exchanges
| Lobbyist | Covered position, as disclosed |
|---|---|
| AMY CHEVALIER EFANTIS | — |
| JONATHAN REA MCPHERSON | — |
| PAUL ROMNESS | — |
| ALANNA PORTER TEMME | — |
Trade (domestic/foreign) TRD
Transatlantic Trade & Investment Partnership (TTIP) - Proposed Free Trade Agreement between the European Union and the United States. (Market Access; Industry-Specific Regulation; Broader Rules and Principles and Modes of Co-operation)
| Lobbyist | Covered position, as disclosed |
|---|---|
| PAUL ROMNESS | — |
| ALANNA PORTER TEMME | — |
Medicare/Medicaid MMM
Average Sales Price; Reimbursement
| Lobbyist | Covered position, as disclosed |
|---|---|
| AMY CHEVALIER EFANTIS | — |
Budget/Appropriations BUD
Rebates for Dual Eligibles and Low Income Subsidy Populations in Medicare Part D; Importation; Non Interference
| Lobbyist | Covered position, as disclosed |
|---|---|
| AMY CHEVALIER EFANTIS | — |
| JONATHAN REA MCPHERSON | — |
| ALANNA PORTER TEMME | — |
Consumer Issues/Safety/Products CSP
Food and Drug Administration Safety & Innovation Act (FDASIA)
| Lobbyist | Covered position, as disclosed |
|---|---|
| AMY CHEVALIER EFANTIS | — |
| JONATHAN REA MCPHERSON | — |
| PAUL ROMNESS | — |
| ALANNA PORTER TEMME | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.